[Post-hemolytic renal failure in children with glucose-6-phosphate dehydrogenase deficiency at the University

B Balaka1, D Agbèrè, P Bonkoungou

  • 1Service de Pédiatrie, Centre hospitalier universitaire de Lomé, Togo. bbalaka@favo.net

Insights

In children with glucose-6-phosphate dehydrogenase deficiency (G6PD), multiple infections and drug combinations are key factors leading to acute hemolysis and severe kidney failure. Early identification and management are crucial for better outcomes.

Area of Science:

  • Pediatric Nephrology
  • Hematology
  • Clinical Pharmacology

Context:

  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common genetic disorder, particularly prevalent in tropical regions.
  • Hemolysis and subsequent renal failure pose significant health risks in affected children.
  • Identifying triggers for these complications is vital for effective clinical management.

Purpose:

  • To determine predisposing factors for acute hemolysis and post-hemolytic renal failure in children with G6PD deficiency.
  • To evaluate the role of hemolytic agents, infections, and drug associations in precipitating these adverse events.
  • To assess the outcomes and management strategies for hemolysis and renal failure in this pediatric population.

Summary:

  • G6PD deficiency was identified in 32.1% of children with hemoglobinuria.
  • Anuric renal failure occurred in 35.1% of G6PD-deficient patients, often linked to infections and drug combinations.
  • Multiple-germ infections and drug associations were identified as primary risk factors for renal failure, with an 80.7% reversibility rate.

Impact:

  • Highlights the critical role of infections and drug interactions in G6PD-related hemolysis and renal failure.
  • Suggests that local endemic infections in tropical areas may contribute significantly to these complications.
  • Informs clinical practice regarding the avoidance of specific triggers and the importance of prompt management in G6PD-deficient children.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...